Investigating the mechanisms of the inhibitory effects of hesperidin against cancer cells using in vitro and in silico techniques48 showed a considerable downregulation of ALDH1, MMP‐9, Bcl‐2 and p21 accompanied by an increase in p53 and cyclin D1. This evidence concerns the gene TP53 and cancer.